{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:44:01Z","timestamp":1785804241804,"version":"3.56.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100007452","name":"WU JIEPING Medical Foundation","doi-asserted-by":"crossref","award":["320.6750.2024-15-29)"],"award-info":[{"award-number":["320.6750.2024-15-29)"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Bethune Charitable Foundation","award":["2024-YJ-156-J-015"],"award-info":[{"award-number":["2024-YJ-156-J-015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-05083-w","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T15:54:07Z","timestamp":1780156447000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between triglyceride levels and upper urinary tract calcium stones recurrence"],"prefix":"10.1186","volume":"27","author":[{"given":"Jiawen","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangwei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minchao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianlin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"issue":"9","key":"5083_CR1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s00345-017-2008-6","volume":"35","author":"I Sorokin","year":"2017","unstructured":"Sorokin I, Mamoulakis C, Miyazawa K, Rodgers A, Talati J, Lotan Y. Epidemiology of stone disease across the world. World J Urol. 2017;35(9):1301\u201320.","journal-title":"World J Urol"},{"issue":"12","key":"5083_CR2","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.7326\/0003-4819-111-12-1006","volume":"111","author":"J Uribarri","year":"1989","unstructured":"Uribarri J, Oh MS, Carroll HJ. The first kidney stone. Ann Intern Med. 1989;111(12):1006\u20139.","journal-title":"Ann Intern Med"},{"issue":"3","key":"5083_CR3","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.juro.2012.05.078","volume":"189","author":"SR Khan","year":"2013","unstructured":"Khan SR. Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations. J Urol. 2013;189(3):803\u201311.","journal-title":"J Urol"},{"issue":"4","key":"5083_CR4","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1517\/14656566.2013.775250","volume":"14","author":"H Xu","year":"2013","unstructured":"Xu H, Zisman AL, Coe FL, Worcester EM. Kidney stones: an update on current pharmacological management and future directions. Expert Opin Pharmacother. 2013;14(4):435\u201347.","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"5083_CR5","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/ndt\/gfu350","volume":"30","author":"L Shavit","year":"2015","unstructured":"Shavit L, Ferraro PM, Johri N, Robertson W, Walsh SB, Moochhala S, Unwin R. Effect of being overweight on urinary metabolic risk factors for kidney stone formation. Nephrol dialysis transplantation: official publication Eur Dialysis Transpl Association - Eur Ren Association. 2015;30(4):607\u201313.","journal-title":"Nephrol dialysis transplantation: official publication Eur Dialysis Transpl Association - Eur Ren Association"},{"issue":"9","key":"5083_CR6","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.3109\/0886022X.2012.713298","volume":"34","author":"M Inci","year":"2012","unstructured":"Inci M, Demirtas A, Sarli B, Akinsal E, Baydilli N. Association between body mass index, lipid profiles, and types of urinary stones. Ren Fail. 2012;34(9):1140\u20133.","journal-title":"Ren Fail"},{"issue":"3","key":"5083_CR7","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.juro.2013.09.022","volume":"191","author":"FC Torricelli","year":"2014","unstructured":"Torricelli FC, De SK, Gebreselassie S, Li I, Sarkissian C, Monga M. Dyslipidemia and kidney stone risk. J Urol. 2014;191(3):667\u201372.","journal-title":"J Urol"},{"issue":"1","key":"5083_CR8","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s12876-025-03954-4","volume":"25","author":"J Lu","year":"2025","unstructured":"Lu J, Wang Z, Mei W, Peng K, Zhang L, Wang G, Xu K, Wang Z, Peng Y, Lu Z, et al. A systematic review of the epidemiology and risk factors for severity and recurrence of hypertriglyceridemia-induced acute pancreatitis. BMC Gastroenterol. 2025;25(1):374.","journal-title":"BMC Gastroenterol"},{"key":"5083_CR9","doi-asserted-by":"publisher","first-page":"1710007","DOI":"10.3389\/fendo.2025.1710007","volume":"16","author":"L Havelda","year":"2025","unstructured":"Havelda L, Szalai E, Obeidat M, Dobszai D, Veres DS, K\u00f3i T, Sipter E, V\u00e1ncsa S, Hegyi PJ, Bucur M, et al. Hypertriglyceridemia is a dose-dependent risk factor for type 2 diabetes mellitus: a systematic review and meta-analysis. Front Endocrinol. 2025;16:1710007.","journal-title":"Front Endocrinol"},{"issue":"4","key":"5083_CR10","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.urology.2014.06.013","volume":"84","author":"HW Kang","year":"2014","unstructured":"Kang HW, Seo SP, Kim WT, Kim YJ, Yun SJ, Lee SC, Kim WJ. Hypertriglyceridemia is associated with increased risk for stone recurrence in patients with urolithiasis. Urology. 2014;84(4):766\u201371.","journal-title":"Urology"},{"key":"5083_CR11","doi-asserted-by":"crossref","unstructured":"Hung JA, Li CH, Geng JH, Wu DW, Chen SC. Dyslipidemia increases the risk of incident kidney stone disease in a large taiwanese population follow-up study. Nutrients. 2022;14(7):1339.","DOI":"10.3390\/nu14071339"},{"key":"5083_CR12","doi-asserted-by":"publisher","first-page":"774567","DOI":"10.3389\/fendo.2021.774567","volume":"12","author":"Z Qin","year":"2021","unstructured":"Qin Z, Zhao J, Geng J, Chang K, Liao R, Su B. Higher Triglyceride-Glucose Index Is Associated With Increased Likelihood of Kidney Stones. Front Endocrinol. 2021;12:774567.","journal-title":"Front Endocrinol"},{"issue":"6","key":"5083_CR13","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.21037\/tau-2025-143","volume":"14","author":"Y Tang","year":"2025","unstructured":"Tang Y, Cai X, Chen L. Exploring the relationship between triglyceride-glucose index and kidney stones in Chinese adults: a cross-sectional study. Translational Androl Urol. 2025;14(6):1542\u201350.","journal-title":"Translational Androl Urol"},{"key":"5083_CR14","doi-asserted-by":"publisher","first-page":"175628722514108","DOI":"10.1177\/17562872251410865","volume":"18","author":"Y Feng","year":"2026","unstructured":"Feng Y, Du C, Hu J, Tan W, Wu J, Yang Y. Association between components of metabolic syndrome and risk of urinary stone recurrence: a single-center case-control study. Ther Adv Urol. 2026;18:17562872251410865.","journal-title":"Ther Adv Urol"},{"issue":"1","key":"5083_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12894-022-01017-4","volume":"22","author":"K Wang","year":"2022","unstructured":"Wang K, Ge J, Han W, Wang D, Zhao Y, Shen Y, Chen J, Chen D, Wu J, Shen N, et al. Risk factors for kidney stone disease recurrence: a comprehensive meta-analysis. BMC Urol. 2022;22(1):62.","journal-title":"BMC Urol"},{"issue":"4","key":"5083_CR16","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.eururo.2024.05.029","volume":"86","author":"A Skolarikos","year":"2024","unstructured":"Skolarikos A, Somani B, Neisius A, Jung H, Pet\u0159\u00edk A, Tailly T, Davis N, Tzelves L, Geraghty R, Lombardo R, et al. Metabolic Evaluation and Recurrence Prevention for Urinary Stone Patients: An EAU Guidelines Update. Eur Urol. 2024;86(4):343\u201363.","journal-title":"Eur Urol"},{"issue":"36","key":"5083_CR17","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","volume":"45","author":"C Vrints","year":"2024","unstructured":"Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, Banning AP, Budaj A, Buechel RR, Chiariello GA, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45(36):3415\u2013537.","journal-title":"Eur Heart J"},{"key":"5083_CR18","unstructured":"Sapra A, Bhandari P. Diabetes. In: StatPearls. edn. Treasure Island (FL) ineligible companies. Disclosure: Priyanka Bhandari declares no relevant financial relationships with ineligible companies.: StatPearls Publishing."},{"issue":"1","key":"5083_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1053\/j.ackd.2017.10.005","volume":"25","author":"BW Teo","year":"2018","unstructured":"Teo BW, Zhang L, Guh JY, Tang SCW, Jha V, Kang DH, Tanchanco R, Hooi LS, Praditpornsilpa K, Kong X, et al. Glomerular Filtration Rates in Asians. Adv Chronic Kidney Dis. 2018;25(1):41\u20138.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"3","key":"5083_CR20","doi-asserted-by":"publisher","first-page":"e13916","DOI":"10.1111\/apha.13916","volume":"237","author":"L Kiss","year":"2023","unstructured":"Kiss L, F\u0171r G, Pisipati S, Rajalingamgari P, Ewald N, Singh V, Rakonczay Z. Jr.: Mechanisms linking hypertriglyceridemia to acute pancreatitis. Acta Physiologica (Oxford England). 2023;237(3):e13916.","journal-title":"Acta Physiologica (Oxford England)"},{"key":"5083_CR21","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3389\/fendo.2020.00616","volume":"11","author":"LS Santos-Baez","year":"2020","unstructured":"Santos-Baez LS, Ginsberg HN. Hypertriglyceridemia-Causes, Significance, and Approaches to Therapy. Front Endocrinol. 2020;11:616.","journal-title":"Front Endocrinol"},{"issue":"17","key":"5083_CR22","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1056\/NEJM199304293281702","volume":"328","author":"MH Criqui","year":"1993","unstructured":"Criqui MH, Heiss G, Cohn R, Cowan LD, Suchindran CM, Bangdiwala S, Kritchevsky S, Jacobs DR Jr., O\u2019Grady HK, Davis CE. Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med. 1993;328(17):1220\u20135.","journal-title":"N Engl J Med"},{"issue":"11","key":"5083_CR23","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1001\/jama.1996.03540110036029","volume":"276","author":"MJ Stampfer","year":"1996","unstructured":"Stampfer MJ, Krauss RM, Ma J, Blanche PJ, Holl LG, Sacks FM, Hennekens CH. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA. 1996;276(11):882\u20138.","journal-title":"JAMA"},{"issue":"2","key":"5083_CR24","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1161\/CIRCOUTCOMES.115.002104","volume":"9","author":"R Klempfner","year":"2016","unstructured":"Klempfner R, Erez A, Sagit BZ, Goldenberg I, Fisman E, Kopel E, Shlomo N, Israel A, Tenenbaum A. Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease: Twenty-Two-Year Follow-Up of the Bezafibrate Infarction Prevention Study and Registry. Circulation Cardiovasc Qual outcomes. 2016;9(2):100\u20138.","journal-title":"Circulation Cardiovasc Qual outcomes"},{"issue":"3","key":"5083_CR25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1001\/jama.298.3.299","volume":"298","author":"BG Nordestgaard","year":"2007","unstructured":"Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007;298(3):299\u2013308.","journal-title":"JAMA"},{"issue":"9","key":"5083_CR26","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1001\/jama.2022.12609","volume":"328","author":"K Walter","year":"2022","unstructured":"Walter K. Kidney Stones. JAMA. 2022;328(9):898.","journal-title":"JAMA"},{"issue":"8","key":"5083_CR27","first-page":"490","volume":"99","author":"LF Fontenelle","year":"2019","unstructured":"Fontenelle LF, Sarti TD. Kidney Stones: Treatment and Prevention. Am Family Phys. 2019;99(8):490\u20136.","journal-title":"Am Family Phys"},{"issue":"4","key":"5083_CR28","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1046\/j.1464-410X.1996.09324.x","volume":"77","author":"SR Khan","year":"1996","unstructured":"Khan SR, Glenton PA. Increased urinary excretion of lipids by patients with kidney stones. Br J Urol. 1996;77(4):506\u201311.","journal-title":"Br J Urol"},{"issue":"6","key":"5083_CR29","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1046\/j.1523-1755.2002.00676.x","volume":"62","author":"SR Khan","year":"2002","unstructured":"Khan SR, Glenton PA, Backov R, Talham DR. Presence of lipids in urine, crystals and stones: implications for the formation of kidney stones. Kidney Int. 2002;62(6):2062\u201372.","journal-title":"Kidney Int"},{"issue":"6","key":"5083_CR30","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1053\/j.ajkd.2012.12.028","volume":"61","author":"Y Kohjimoto","year":"2013","unstructured":"Kohjimoto Y, Sasaki Y, Iguchi M, Matsumura N, Inagaki T, Hara I. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan. Am J kidney diseases: official J Natl Kidney Foundation. 2013;61(6):923\u20139.","journal-title":"Am J kidney diseases: official J Natl Kidney Foundation"},{"issue":"4","key":"5083_CR31","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.urology.2011.03.007","volume":"78","author":"IH Chang","year":"2011","unstructured":"Chang IH, Lee YT, Lee DM, Kim TH, Myung SC, Kim YS, Ahn SH. Metabolic syndrome, urine pH, and time-dependent risk of nephrolithiasis in Korean men without hypertension and diabetes. Urology. 2011;78(4):753\u20138.","journal-title":"Urology"},{"issue":"9","key":"5083_CR32","doi-asserted-by":"publisher","first-page":"sfaf244","DOI":"10.1093\/ckj\/sfaf244","volume":"18","author":"A Zomorodian","year":"2025","unstructured":"Zomorodian A, Moe OW. Citrate and calcium kidney stones. Clin kidney J. 2025;18(9):sfaf244.","journal-title":"Clin kidney J"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05083-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05083-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05083-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:47:29Z","timestamp":1785800849000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-05083-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5083"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05083-w","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"16 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study complied with the Declaration of Helsinki and was approved by Sir Run Run Hospital Nanjing Medical University Ethics Committee (2022-SR-042). All participants signed the informed consent forms.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"453"}}